CSS
BLFS icon

Cubist Systematic Strategies’s BioLife Solutions BLFS Stock Holding History

Cubist Systematic Strategies’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,657
Closed -$36K – 3535
2023
Q1 		$36K Buy
+1,657
New +$37.3K ﹤0.01% 3609
2022
Q4 		– Sell
-16,992
Closed -$387K – 4253
2022
Q3 		$387K Buy
+16,992
New +$364K ﹤0.01% 3351
2022
Q2 		– Sell
-44,686
Closed -$1.02M – 4360
2022
Q1 		$1.02M Buy
+44,686
New +$1.18M 0.01% 2007

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Cubist Systematic Strategies's BLFS Position: Q2 2023 in Review

Cubist Systematic Strategies sold out of BioLife Solutions (BLFS) in Q2 2023, closing a stake of 1,657 shares — an estimated $36K sold.

Cubist Systematic Strategies first reported a position in BLFS in Q1 2022 and held it in 3 quarters. The position peaked at $1.02M in Q1 2022. 156 funds tracked by Wall St. Rank hold BLFS as of Q2 2023.

  • Cubist Systematic Strategies reported no remaining BioLife Solutions position as of Q2 2023 after selling out during the quarter.
  • Cubist Systematic Strategies sold 1,657 BioLife Solutions shares in Q2 2023, an estimated $36K.
  • Cubist Systematic Strategies first reported a position in BioLife Solutions in Q1 2022 and held it in 3 quarters.
  • Cubist Systematic Strategies's BioLife Solutions position peaked at $1.02M in Q1 2022.
  • 156 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2023.

Based on Cubist Systematic Strategies's 13F filing for Q2 2023, filed 14 Aug 2023.